お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
534674

世界の注射剤市場:2017~2021年

Global Injectable Drugs Market 2017-2021

出版日: | 発行: TechNavio (Infiniti Research Ltd.) | ページ情報: 英文 84 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.75円
世界の注射剤市場:2017~2021年
出版日: 2017年07月26日
発行: TechNavio (Infiniti Research Ltd.)
ページ情報: 英文 84 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

注射剤は、シリンジや中空針を使って体内に直接注入される薬剤です。様々な注入方法がある中、皮下注射、筋肉注射、静脈注射が主なものとなっています。世界の注射剤市場は2017~2021年にかけCAGR8.21%で拡大するとみられています。

当レポートでは、世界の注射剤市場について調査し、市場の動向と課題、分子タイプ別、地域別動向、および市場に参入する主要ベンダーのプロファイルなどをまとめています。

第1章 エグゼクティブサマリー

第2章 当レポートの範囲

第3章 調査方法

第4章 イントロダクション

第5章 市況

  • 市場概要
  • 市場規模と予測
  • ファイブフォース分析

第6章 パイプライン環境

第7章 分子タイプ別市場セグメンテーション

  • 生物製剤
  • 小分子

第8章 地域別セグメンテーション

  • 南北アメリカ
  • 欧州・中東・アフリカ
  • アジア太平洋地域

第9章 意思決定の枠組み

第10章 促進因子と課題

第11章 市場動向

  • 意識の向上が高い需要につながる
  • 産学連携の増加
  • 新規ワクチンの参入見込み
  • バイオシミラーの登場

第12章 ベンダー環境

  • 競合環境

第13章 主要ベンダー分析

  • AbbVie
  • F. Hoffmann-La Roche
  • GlaxoSmithKline
  • Sanofi
  • その他の注目ベンダー

第14章 付録

目次
Product Code: IRTNTR13955

About Injectable Drugs

Injectable drugs are directly infused into the body with the help of a syringe and a hollow needle. Various modes of infusion are used for the drug delivery. Among them, subcutaneous (SC), intramuscular (IM), and intravenous (IV) are the three major modes. The market encompasses drugs that are used for the prevention and cure of various diseases, and are mainly of two types, namely, biologics and small molecule drugs.

Technavio's analysts forecast the global injectable drugs market to grow at a CAGR of 8.21% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global injectable drugs market for 2017-2021. To calculate the market size, the report considers the sales of vaccines, branded, generic, and off-label drugs.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Injectable Drugs Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • AbbVie
  • F. Hoffmann-La Roche
  • GlaxoSmithKline
  • Sanofi

Other Prominent Vendors

  • Bayer
  • Bristol-Myers Squibb
  • Merck
  • Takeda Pharmaceutical
  • Teva Pharmaceutical

Market driver

  • Escalation in demand for self-injection devices
  • For a full, detailed list, view our report

Market challenge

  • High cost of production
  • For a full, detailed list, view our report

Market trend

  • Increase in industry-academia collaboration
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

  • Market outline
  • ROA

PART 05: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 06: Pipeline landscape

PART 07: Market segmentation by molecule type

  • Biologics
  • Small molecules

PART 08: Geographical segmentation

  • Injectable drugs market in Americas
  • Injectable drugs market in EMEA
  • Injectable drugs market in APAC

PART 09: Decision framework

PART 10: Drivers and challenges

  • Market drivers
  • Market challenges

PART 11: Market trends

  • Rising awareness leading to high demand for injectable drugs
  • Increase in industry-academia collaboration
  • Expected entry of novel vaccines
  • Advent of biosimilars

PART 12: Vendor landscape

  • Competitive landscape

PART 13: Key vendor analysis

  • AbbVie
  • F. Hoffmann-La Roche
  • GlaxoSmithKline
  • Sanofi
  • Other prominent vendors

PART 14: Appendix

  • List of abbreviations

List of Exhibits

  • Exhibit 01: Market scenario: Global injectable drugs market 2016
  • Exhibit 02: Decisive factors for the choice of ROA
  • Exhibit 03: Major ROA for drugs intake
  • Exhibit 04: Types of injections
  • Exhibit 05: Adverse effects of injectable drugs
  • Exhibit 06: Global injectable drugs market snapshot
  • Exhibit 07: Global injectable drugs market 2016-2021 ($ billions)
  • Exhibit 08: Opportunity analysis in global injectable drugs market
  • Exhibit 09: Five forces analysis
  • Exhibit 10: Pipeline molecules by key vendors (Phase III)
  • Exhibit 11: Key clinical trials of key vendors (Phase III)
  • Exhibit 12: Global injectable drugs market segmentation by molecule type
  • Exhibit 13: Global injectable drugs market segmentation by molecule type 2016 and 2021 (%)
  • Exhibit 14: Global biologics injectable drugs market 2016-2021 ($ billions)
  • Exhibit 15: Top biologic drugs in the injectable drugs market
  • Exhibit 16: Global small molecules injectable drugs market 2016-2021 ($ billions)
  • Exhibit 17: Segmentation of global injectable drugs market based on geography 2016 and 2021 (%)
  • Exhibit 18: Global injectable drugs market by geography 2016-2021 ($ billions)
  • Exhibit 19: Market scenario in Americas
  • Exhibit 20: Injectable drugs market in Americas 2016-2021 ($ billions)
  • Exhibit 21: Market scenario in EMEA
  • Exhibit 22: Injectable drugs market in EMEA 2016-2021 ($ billions)
  • Exhibit 23: Market scenario in APAC
  • Exhibit 24: Injectable drugs market in APAC 2016-2021 ($ billions)
  • Exhibit 25: Major indications finding huge applications of injectable drugs
  • Exhibit 26: Major reasons to use injectable drugs
  • Exhibit 27: New cases of diabetes by 2040
  • Exhibit 28: Major complications involved with the injections
  • Exhibit 29: Major causes of drug shortage
  • Exhibit 30: Competitive structure analysis of global injectable drugs market
  • Exhibit 31: AbbVie: Key highlights
  • Exhibit 32: AbbVie: Strength assessment
  • Exhibit 33: AbbVie: Strategy assessment
  • Exhibit 34: AbbVie: Opportunity assessment
  • Exhibit 35: F. Hoffmann-La Roche: Key highlights
  • Exhibit 36: F. Hoffmann-La Roche: Strength assessment
  • Exhibit 37: F. Hoffmann-La Roche: Strategy assessment
  • Exhibit 38: F. Hoffmann-La Roche: Opportunity assessment
  • Exhibit 39: GlaxoSmithKline: Key highlights
  • Exhibit 40: GlaxoSmithKline: Strength assessment
  • Exhibit 41: GlaxoSmithKline: Strategy assessment
  • Exhibit 42: GlaxoSmithKline: Opportunity assessment
  • Exhibit 43: Sanofi: Key highlights
  • Exhibit 44: Sanofi: Strength assessment
  • Exhibit 45: Sanofi: Strategy assessment
  • Exhibit 46: Sanofi: Opportunity assessment
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.